The Role of Nurses and Pharmacists in Managing Antimicrobial Practices in Patients with Hospital-Acquired Pneumonia

Background: Hospital-acquired pneumonia (HAP) and ventilator-associated pneumonia (VAP) are major healthcare-associated infections that contribute to morbidity, mortality, prolonged hospitalization, and increased healthcare costs. Their management is complicated by multidrug-resistant pathogens, diagnostic limitations, and the clinical complexity of hospitalized patients. Aim: This review examines the epidemiology, etiology, clinical presentation, diagnostic evaluation, treatment, and prognosis of HAP and VAP, with particular emphasis on the complementary roles of nursing and pharmacy professionals in prevention and management. Methods: The review discusses current evidence concerning common bacterial pathogens, risk factors for antimicrobial resistance, clinical and microbiological diagnostic approaches, empirical antimicrobial selection, treatment modification, and infection prevention strategies. It also examines nursing surveillance, medication optimization, antimicrobial stewardship, and multidisciplinary collaboration. Results: HAP and VAP are commonly associated with gram-negative organisms, including Pseudomonas aeruginosa, Klebsiella pneumoniae, and Acinetobacter species, as well as Staphylococcus aureus. Previous intravenous antibiotic exposure and prolonged hospitalization increase the risk of resistant infections. Diagnosis requires integration of clinical findings, radiological evidence, and respiratory cultures, while molecular assays may accelerate pathogen identification. Empirical treatment should reflect local resistance patterns and individual risk factors, followed by culture-guided de-escalation. A seven-day antibiotic course is generally sufficient for uncomplicated cases. Nursing interventions support early detection and infection prevention, whereas pharmacists optimize antimicrobial selection, dosing, safety, and treatment duration. Conclusion: Effective HAP and VAP management requires early diagnosis, appropriate antimicrobial therapy, infection prevention, and coordinated interprofessional care.

Authors

Institutions

Publication Details

Journal
Saudi Journal of Medicine and Public Health
Published
2026-11-18
DOI
https://doi.org/10.64483/202631880
Primary Topic
Nosocomial Infections in ICU
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

The Role of Nurses and Pharmacists in Managing Antimicrobial Practices in Patients with Hospital-Acquired Pneumonia

Albader Mohammed Moafa, Yassir Mohammad Jabbari, Ashwag Mohammed Alasmarei, Suoad Albalawi et al.
Saudi Journal of Medicine and Public Health
Nosocomial Infections in ICU
article

The Role of Nurses and Pharmacists in Managing Antimicrobial Practices in Patients with Hospital-Acquired Pneumonia

Albader Mohammed Moafa, Yassir Mohammad Jabbari, Ashwag Mohammed Alasmarei, Suoad Albalawi, Mohammed Dughyyim Alharbi, Ebtehal Hamod Ali, Sultan Essa Alhatheg, Hussam Mohammed Nasser Zawli, Motaen Darwish Hasan Fageh, Mai Awadh Saeed Alrashidi, Leena Mabrouk Alzaid, Mansour Hassan Ali Alshehri
article en

Abstract

Background: Hospital-acquired pneumonia (HAP) and ventilator-associated pneumonia (VAP) are major healthcare-associated infections that contribute to morbidity, mortality, prolonged hospitalization, and increased healthcare costs. Their management is complicated by multidrug-resistant pathogens, diagnostic limitations, and the clinical complexity of hospitalized patients. Aim: This review examines the epidemiology, etiology, clinical presentation, diagnostic evaluation, treatment, and prognosis of HAP and VAP, with particular emphasis on the complementary roles of nursing and pharmacy professionals in prevention and management. Methods: The review discusses current evidence concerning common bacterial pathogens, risk factors for antimicrobial resistance, clinical and microbiological diagnostic approaches, empirical antimicrobial selection, treatment modification, and infection prevention strategies. It also examines nursing surveillance, medication optimization, antimicrobial stewardship, and multidisciplinary collaboration. Results: HAP and VAP are commonly associated with gram-negative organisms, including Pseudomonas aeruginosa, Klebsiella pneumoniae, and Acinetobacter species, as well as Staphylococcus aureus. Previous intravenous antibiotic exposure and prolonged hospitalization increase the risk of resistant infections. Diagnosis requires integration of clinical findings, radiological evidence, and respiratory cultures, while molecular assays may accelerate pathogen identification. Empirical treatment should reflect local resistance patterns and individual risk factors, followed by culture-guided de-escalation. A seven-day antibiotic course is generally sufficient for uncomplicated cases. Nursing interventions support early detection and infection prevention, whereas pharmacists optimize antimicrobial selection, dosing, safety, and treatment duration. Conclusion: Effective HAP and VAP management requires early diagnosis, appropriate antimicrobial therapy, infection prevention, and coordinated interprofessional care.

Saudi Journal of Medicine and Public HealthVol. 3(1)
Imam Abdulrahman Al Faisal Hospital (SA), Ministry of Health (SA), Ministry of Health (MM), Jazan University (SA)
Nosocomial Infections in ICU
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon